My Background

I have had the priviledge of being involved in the optimization and development of EchoGen at Sonus Pharmaceuticals and in the development of Ampalex (CX516) and the second generation Ampakine, CX691, at Cortex Pharmaceuticals.

I have been involved with drug discovery, medicinal chemistry, formulation optimization, outsourcing, GMP synthesis, drug manufacturing, analytical method development, release and stability testing, and quality assurance.

Company Links

Cortex Pharmaceuticals

Innovator in the discovery and development of drugs to treat depression schizophrenia, and Alzheimer's disease

Sonus Pharmaceuticals

Originator and leader in the development of fluorocarbon ultrasound contrast agents and emulsion based parenteral pharmaceuticals